Prospective Trial Shows PAM50 Biomarker Predicts Hormone Therapy Benefit in Prostate Cancer
Study finds molecular signature identifies which men with recurrent disease respond to apalutamide plus salvage radiation therapy.
Read More
Search Results for: Indica lab
AI-Powered Sepsis Test Shows Promise in Large Clinical Study
TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.
Read More
AI-Driven Platform Aims to Bring Personalized Cancer Treatment to More Patients
First Ascent Biomedical is validating a live-cell testing platform that screens over 150 FDA-approved therapies against a patient’s tumor, generating individualized treatment insights in about 10 days.
Read More
Women’s Health Platform to Offer Home STI Test
The test uses Abbott’s simpli-COLLECT platform to detect chlamydia, gonorrhea, trichomonas, and mycoplasma genitalium from patient-collected specimens.
Read More
bioMérieux Receives FDA Clearance for Anterior Nasal Swab Testing on Spotfire Platform
The French diagnostics company announced the clearance allows healthcare professionals to collect specimens by swabbing only the anterior part of the nasal cavity.
Read More